Skip to main content

Where to find accurate information on news about drugs for Alzheimer's disease

The recent publication of a clinical trial for a drug (Aducanumab) being developed to treat Alzheimer's disease has hit the mainstream media big time. In all of this commotion, especially when the reporting may not have been written by someone familiar with the field, it can be easy for people to get swept away by the huge media buzz and feel like "this is it! the new wonder drug everyone has been waiting for is finally here!" 

Except that's not quite the case, as it rarely ever is when a scientific story hits the news. Whether its the BBC, online science blogs or your tabloid newspaper of preference, all of these news outlets are competing for your attention and are striving to be the first to break the story. 

I won't go through the study myself, because I'm about to point you to two excellent sources that have already done a brilliant job of it, but there are a few things I want people to clearly see:

  • This is quite an early study and the failure rate of drugs that have reached this stage is still high, especially in Alzheimer's


  • It's primary aim is to show the safety and tolerability of the drug, it is not designed to give clear evidence about its effects on cognition, as the cognitive measurements were clearly listed as "exploratory"

So where can you go to find trustworthy information about science in the news? 

This can be quite difficult, especially depending on the subject, but the NHS has a special Behind the Headlines section which often does an excellent job of giving you the information you need, along with the explanation of how it fits into the rest of the scientific picture. 

Their article on the Aducanumab drug trial is available here

For this specific news article, I would recommend you read this excellent article by my old course-mate for Alzheimer's Research UK

In future you might want to check out healthnewsreviews.org which has a team of experts that voluntarily review health news stories and press releases.
You might also want to try and access the original scientific paper. These are often more balanced and cautious than the media coverage itself, but journals often require a subscription or some other form of payment to access the full papers. In future you will see more and more journals that make their articles free to anyone (called open access), but the most prestigious journals that hold most of the major stories still require payment. 

Alternatively, if you just want to know more about the set up of a clinical trial, rather than the results, you can check clinical trials databases such as clinicaltrials.gov or EU clinical trials register. You may need to find the clinical trial number in order to find the study you're looking for though.

If you do decide to read scientific papers or clinical trials databases for yourself, health news reviews has a good section for Tips for Understanding Studies. Wherever you get your science news from though, it's always a good idea to try and look a little bit deeper. 


Comments

Popular posts from this blog

Medical Writing: Do you need a PhD?

When I was looking into becoming a medical writer, I was just at the end of my MSc and trying to decide whether to try and get a job in medical communications or to do a PhD and then move into Med Comms later. The short answer is no you don't necessarily need  a PhD to be a medical writer, but some employers think you do and it certainly seems to be the ideal.  After looking around on the internet I found a few forum posts asking about the same thing, "should I do a PhD to get into Med Comms?”. Most people said no not necessarily. But as far as I could tell, all of them did have PhD’s and were just telling people well maybe yes and maybe no. Since getting a job as an associate medical writer without a PhD, I've heard a lot more of this conversation occurring within the industry and especially at careers fairs. A lot of people  do  have PhD’s and quite often post-doctoral experience. But that is normally because they started out in academia and...

Introducing...TEDxUoN 2015!

TED (Technology, Entertainment, Design) is a global initiative dedicated to "ideas worth spreading". They host global conferences with the most inspirational speakers imaginable; from leading scientists upheaving our understanding of the world and our entire universe, to world-class performance acts and those select few people who have the mixture of brilliance and insanity required to make real change in the world. If you're new to TED, you MUST watch their videos,  here's a link to their best videos ! TEDx is a spin off of TED global, in which independent groups (a university society, perhaps) host their own events in the spirit of TED, but in a completely original way. This is where TEDxUoN comes in. We are a society of students who were inspired by the global TED conferences and set up our own events. We host a series of mini TED-style talks on a regular basis and also small events, such as TEDx-Action! and TEDx- The Fusion of Science & Art. But t...

IDH1 and Brain Tumours: What's It All About?

In a recent publication in Nature a vaccine was created against a mutated IDH1 gene that prevented growth of brain tumours in mice, with human trials next in the pipeline. But what does this actually mean?  First, this mutation is found in about 70% of gliomas, a brain tumour that appear to be made up of glial cells (the support cells of the brain), these tend to be quite slow growing, however Glioblastoma Multiforme (GBM) is one of the most aggressive and deadly forms of cancer possible. Around 5000 people die from brain tumours in the UK every year, with a much greater proportion of children developing brain tumours than other forms of cancer.  What is IDH1? The IDH1 gene is involved in metabolism, and plays a role in the production of a chemical called 2-oxyglutarate (2OG), which is essential for the function of other proteins that regulate a process called DNA methylation, which helps to control the expression of many different genes. When IDH1 is mutated (almost alw...